RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: osteoarthritis
Accession: DOID:8398
browse the term
Definition: An arthritis that has_material_basis_in worn out cartilage located_in joint. (DO)
Synonyms: exact_synonym: DIPOA; Degenerative Arthritis; GOA1; OA; OADIP; OSTEOARTHRITIS OF DISTAL INTERPHALANGEAL JOINTS; OSTEOARTHRITIS OF KNEE/HIP; OSTEOARTHRITIS, GENERALIZED, WITHOUT DYSPLASIA; Osteoarthroses; Osteoarthrosis; degenerative arthritides; degenerative joint disease; hypertrophic arthritis; osteoarthritides; osteoarthrosis and allied disorder; osteoarthrosis deformans
narrow_synonym: HAND OSTEOARTHRITIS; HOA HEBERDEN NODES; osteoarthritis, toe
related_synonym: OS1; OS2; OS3; OS4; OS5; OS6; osteoarthritis susceptibility 1; osteoarthritis susceptibility 2; osteoarthritis susceptibility 3; osteoarthritis susceptibility 4; osteoarthritis susceptibility 5; osteoarthritis susceptibility 6
primary_id: MESH:D010003
alt_id: OMIM:140600 ; OMIM:165720 ; OMIM:607850 ; OMIM:610839 ; OMIM:612400 ; OMIM:612401
xref: EFO:0002506 ; EFO:1000788 ; ICD9CM:715.3 ; MONDO:0005178 ; NCI:C3293
For additional species annotation, visit the
Alliance of Genome Resources .
G
Acaa2
acetyl-CoA acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
G
Acan
aggrecan
treatment
ISO IEP
RGD
PMID:22833446 PMID:21853458
RGD:11570535 , RGD:11570544
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
G
Aco1
aconitase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Actb
actin, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Adam12
ADAM metallopeptidase domain 12
susceptibility
ISO
RGD
PMID:15334463
RGD:1625347
NCBI chr 1:188,686,984...189,014,206
Ensembl chr 1:188,686,989...189,020,667
G
Adam15
ADAM metallopeptidase domain 15
ISO
RGD
PMID:15818704
RGD:1559176
NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113
G
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif, 14
ISO
DNA:missense mutation:cds: (rs4747096) (human)
RGD
PMID:18790654
RGD:6771189
NCBI chr20:29,143,029...29,219,846
Ensembl chr20:29,144,354...29,219,866
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
treatment
ISO
associated with Bone Diseases, Metabolic
RGD
PMID:22432033
RGD:10043110
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Adamts5
ADAM metallopeptidase with thrombospondin type 1 motif, 5
treatment disease_progression no_association
ISO IEP IMP
associated with Bone Diseases, Metabolic mRNA:increased expression:cartilage protein:alternative form:synovium DNA:missense mutations:exon: (rs226794, rs2830585) (human) DNA:missense mutation:exon:p.R614H (human)
RGD
PMID:23982761 PMID:22432033 PMID:17530714 PMID:22084394 PMID:23954517 PMID:11801682 PMID:18240210 PMID:23546441 PMID:22961118 More...
RGD:10043101 , RGD:10043110 , RGD:2300093 , RGD:10003165 , RGD:10043107 , RGD:10043106 , RGD:10043105 , RGD:10043103 , RGD:10043102
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
G
Adgrg2
adhesion G protein-coupled receptor G2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
G
Ager
advanced glycosylation end product-specific receptor
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16948116 PMID:23894457
RGD:8695985
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Ak4
adenylate kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Akr1c1
aldo-keto reductase family 1, member C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24728293
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Aspn
asporin
no_association
ISO
DNA:repeats:exon: CTD Direct Evidence: marker/mechanism
OMIM CTD RGD
PMID:16542493
RGD:9684966
NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
G
Atp6v1b2
ATPase H+ transporting V1 subunit B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr16:20,617,515...20,641,651
Ensembl chr16:20,617,518...20,641,745
G
Atp7a
ATPase copper transporting alpha
ISS
OMIM:140600 | OMIM:165720 | OMIM:607850 | OMIM:612400
MouseDO
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Bad
BCL2-associated agonist of cell death
ISO
RGD
PMID:19217321
RGD:10053643
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bag6
BAG cochaperone 6
susceptibility
ISO
DNA:SNP: :rs3117582(human)
RGD
PMID:25231575
RGD:14390133
NCBI chr20:3,675,938...3,690,414
Ensembl chr20:3,675,938...3,688,657
G
Bax
BCL2 associated X, apoptosis regulator
ISO
protein:increased expression:chondrocyte
RGD
PMID:19217321 PMID:16864079
RGD:10053643 , RGD:10054095
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
ISO
protein:increased expression:chondrocyte
RGD
PMID:19217321 PMID:16864079
RGD:10053643 , RGD:10054095
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Becn1
beclin 1
ISO
protein:decreased expression:cartilage
RGD
PMID:20187128 PMID:20187128
RGD:6483317 , RGD:6483317
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bglap
bone gamma-carboxyglutamate protein
disease_progression
ISO
RGD
PMID:20157712
RGD:6483599
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Bmp2
bone morphogenetic protein 2
susceptibility
ISO
RGD
PMID:15334463
RGD:1625347
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
G
Bmp4
bone morphogenetic protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Bmp6
bone morphogenetic protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Bmp7
bone morphogenetic protein 7
ISS
OMIM:140600 | OMIM:165720 | OMIM:607850 | OMIM:610839 | OMIM:612400 | OMIM:612401
MouseDO
NCBI chr 3:161,639,915...161,716,938
Ensembl chr 3:161,516,462...161,716,788
G
Bmpr1a
bone morphogenetic protein receptor type 1A
ISS
OMIM:140600 | OMIM:165720 | OMIM:607850 | OMIM:610839 | OMIM:612400 | OMIM:612401
MouseDO
NCBI chr16:9,736,390...9,829,825
Ensembl chr16:9,736,630...9,780,616
G
Calca
calcitonin-related polypeptide alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16690336
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:29138829
RGD:13782343
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
treatment
IEP
RGD
PMID:29138829
RGD:13782343
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cav1
caveolin 1
IEP
RGD
PMID:16508959
RGD:10043354
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccl22
C-C motif chemokine ligand 22
ISO
protein:increased expression:plasma:
RGD
PMID:19942450
RGD:10054497
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccr4
C-C motif chemokine receptor 4
ISO
protein:increased expression:synovial membrane:
RGD
PMID:19942450
RGD:10054497
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
G
Cd36
CD36 molecule
susceptibility
ISO
RGD
PMID:15334463
RGD:1625347
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
treatment
IEP
RGD
PMID:24009074
RGD:10043190
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cebpb
CCAAT/enhancer binding protein beta
susceptibility
ISO
RGD
PMID:22095691
RGD:10401214
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Chi3l1
chitinase 3 like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
G
Cilp
cartilage intermediate layer protein
disease_progression
ISO
RGD
PMID:15334463
RGD:1625347
NCBI chr 8:65,777,281...65,792,251
Ensembl chr 8:65,777,281...65,792,251
G
Clec3b
C-type lectin domain family 3, member B
disease_progression
ISO
RGD
PMID:15334463
RGD:1625347
NCBI chr 8:122,810,120...122,815,837
Ensembl chr 8:122,810,149...122,815,835
G
Clic1
chloride intracellular channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
G
Clic4
chloride intracellular channel 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452
G
Clu
clusterin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789 PMID:18784066
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Col11a1
collagen type XI alpha 1 chain
ISS
OMIM:140600 | OMIM:165720 | OMIM:607850 | OMIM:610839 | OMIM:612400 | OMIM:612401
MouseDO
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
G
Col1a1
collagen type I alpha 1 chain
no_association
ISO
DNA:SNP:intron:IVS1
RGD
PMID:10743824
RGD:5688331
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col2a1
collagen type II alpha 1 chain
onset treatment
ISO IDA
DNA:missense mutation:exon:p.R75C (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9061443 PMID:16189708 PMID:16755660 PMID:19216861
RGD:8657384 , RGD:8661226
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Col6a2
collagen type VI alpha 2 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Col9a1
collagen type IX alpha 1 chain
ISS
OMIM:140600 | OMIM:165720 | OMIM:607850 | OMIM:610839 | OMIM:612400 | OMIM:612401
MouseDO
NCBI chr 9:26,585,034...26,668,222
Ensembl chr 9:26,585,034...26,668,213
G
Comp
cartilage oligomeric matrix protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7670472
NCBI chr16:19,047,206...19,055,584
Ensembl chr16:19,047,207...19,055,845
G
Ctsd
cathepsin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Ctsk
cathepsin K
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30664745
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Dapp1
dual adaptor of phosphotyrosine and 3-phosphoinositides 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 2:226,425,890...226,475,445
Ensembl chr 2:226,425,898...226,475,423
G
Ddr2
discoidin domain receptor tyrosine kinase 2
disease_progression
ISO
RGD
PMID:24938620
RGD:150429973
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Ddx3x
DEAD-box helicase 3, X-linked
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168
G
Dpep1
dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30664745
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
G
Dpysl2
dihydropyrimidinase-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
G
Edil3
EGF like repeats and discoidin domains 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
G
Eef2
eukaryotic translation elongation factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Efemp2
EGF containing fibulin extracellular matrix protein 2
IEP
mRNA:increased expression:articular cartilage of joint (rat)
RGD
PMID:31396630
RGD:42722015
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
G
Egr1
early growth response 1
ISO
RGD
PMID:10806043
RGD:1626498
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
ISS
OMIM:140600 | OMIM:165720 | OMIM:607850 | OMIM:610839 | OMIM:612400 | OMIM:612401
MouseDO
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
G
Epas1
endothelial PAS domain protein 1
ISO
protein:increased expression:layer of synovial tissue, stromal cell mRNA:increased expression:cartilage
RGD
PMID:21869830 PMID:12823854 PMID:20495569 PMID:20495569
RGD:10395364 , RGD:10395366 , RGD:10395365 , RGD:10395365
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
ISO
mRNA:decreased expression:knee, articular cartilage of joint
RGD
PMID:24964749
RGD:10045611
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Erg
ETS transcription factor ERG
ISS
OMIM:140600 | OMIM:165720 | OMIM:607850 | OMIM:610839 | OMIM:612400 | OMIM:612401
MouseDO
NCBI chr11:34,678,614...34,900,951
Ensembl chr11:34,678,618...34,845,871
G
Errfi1
ERBB receptor feedback inhibitor 1
ISS
OMIM:140600 | OMIM:165720 | OMIM:607850 | OMIM:610839 | OMIM:612400 | OMIM:612401
MouseDO
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
G
Esd
esterase D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
G
Esr1
estrogen receptor 1
ISO
DNA:SNP:intron: (rs2234693) (human) DNA:SNPs:introns: (rs2234693, rs9340799) (human)
RGD
PMID:20417295 PMID:19884274
RGD:10045662 , RGD:10045830
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
ISO
DNA:SNP:intron: (rs1256031) (human)
RGD
PMID:19884274
RGD:10045830
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Etfa
electron transfer flavoprotein subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
G
Ezr
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
Fcgr2a
Fc gamma receptor 2A
ISO
RGD
PMID:8254199
RGD:5147984
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fgf18
fibroblast growth factor 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30664745
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
RGD
PMID:22393163
RGD:10402075
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
mRNA:increased expression:trabecular bone:
RGD
PMID:15781004
RGD:10402109
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Fn1
fibronectin 1
ISO
protein:increased expression:cartilage:
RGD
PMID:8646429
RGD:10402156
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Frzb
frizzled-related protein
susceptibility
ISO
ClinVar Annotator: match by term: Osteoarthritis CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:15210948 PMID:25741868
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
G
Ftl1
ferritin light chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gdf5
growth differentiation factor 5
ISO ISS
CTD Direct Evidence: marker/mechanism
OMIM MouseDO CTD
PMID:18830904 PMID:30664745
NCBI chr 3:144,454,316...144,458,508
Ensembl chr 3:144,454,338...144,458,612
G
Gh1
growth hormone 1
ISO
protein:increased expression:plasma
RGD
PMID:7152485
RGD:10003140
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Ghr
growth hormone receptor
ISO
DNA:deletion:exon:
RGD
PMID:23740230
RGD:10003113
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Gls
glutaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
G
Gstk1
glutathione S-transferase kappa 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
G
Hbp1
HMG-box transcription factor 1
ISO
RGD
PMID:22586168
RGD:10402054
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
G
Hfe
homeostatic iron regulator
ISO
DNA:missense mutation: :p.C282Y (rs1800562) (human)
RGD
PMID:30651232
RGD:14746965
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Hibch
3-hydroxyisobutyryl-CoA hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ISO
protein:increased expression:layer of synovial tissue, stromal cell
RGD
PMID:12823854 PMID:18789153
RGD:10395366 , RGD:10402406
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmgb1
high mobility group box 1
ISO
RGD
PMID:22330250
RGD:10401949
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Idh3a
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084
G
Ifna1
interferon, alpha 1
treatment
IEP
RGD
PMID:30456844
RGD:36174218
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
G
Igf1
insulin-like growth factor 1
ISO
protein:decreased expression:blood:
RGD
PMID:2290165
RGD:10045857
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
severity
ISO
mRNA:increased expression:articular cartilage of joint:
RGD
PMID:8609369
RGD:10045889
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igf2
insulin-like growth factor 2
ISO
mRNA:increased expression:cartilage
RGD
PMID:22527881
RGD:10402552
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
RGD
PMID:18775662
RGD:10402575
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Ihh
Indian hedgehog signaling molecule
ISO IEP
protein:increased expression:cartilage
RGD
PMID:24786088 PMID:24786088
RGD:12910979 , RGD:12910979
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
G
Il1a
interleukin 1 alpha
ISO
protein:increased expression:chonodrocyte:
RGD
PMID:9497936
RGD:10047053
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
treatment
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21954917 PMID:22890185
RGD:7207218
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il4r
interleukin 4 receptor
ISO
protein:increased expression:serum
RGD
PMID:16647277
RGD:10402785
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il5
interleukin 5
ISO
RGD
PMID:22035391
RGD:5687147
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Immt
inner membrane mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
G
Ins2
insulin 2
ISO
protein:increased expression:blood:
RGD
PMID:2290165
RGD:10045857
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Isoc2b
isochorismatase domain containing 2b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:68,972,960...68,993,760
Ensembl chr 1:68,972,960...68,993,757
G
Jag1
jagged canonical Notch ligand 1
ISO
RGD
PMID:18354251
RGD:6482239
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
Lep
leptin
severity
ISO
protein:increased expression:tibia, cartilage, chondrocyte (human)
RGD
PMID:14613274
RGD:10053634
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34894372
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Ltbp3
latent transforming growth factor beta binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11790802 PMID:12379497
NCBI chr 1:203,029,412...203,045,975
Ensembl chr 1:203,029,877...203,045,975
G
Matn3
matrilin 3
susceptibility
ISO ISS
ClinVar Annotator: match by term: Osteoarthritis susceptibility 2 CTD Direct Evidence: marker/mechanism
ClinVar OMIM MouseDO CTD
PMID:12736871 PMID:14729835 PMID:25741868 PMID:28492532
NCBI chr 6:31,748,517...31,768,564
Ensembl chr 6:31,748,474...31,768,101
G
Mir146a
microRNA 146a
ISO
mRNA:decreased expression:cartilage tissue (human)
RGD
PMID:31472145
RGD:152177908
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir34a
microRNA 34a
treatment
ISO IMP
mRNA:increased expression:knee, hip (human)
RGD
PMID:30048987 PMID:30048987
RGD:152177909 , RGD:152177909
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
G
Mmp1
matrix metallopeptidase 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:9972954
RGD:7207129
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp13
matrix metallopeptidase 13
treatment
ISO IEP
mRNA, protein:increased expression:cartilage
RGD
PMID:16128596 PMID:11134178 PMID:17530714 PMID:23982761 PMID:22890185
RGD:7207089 , RGD:10043117 , RGD:2300093 , RGD:10043101 , RGD:7207218
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp2
matrix metallopeptidase 2
ISO
protein:increased expression:synovial fluid (human)
RGD
PMID:15194590
RGD:7207131
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp3
matrix metallopeptidase 3
ISO
protein:increased expression:synovial fluid (human)
RGD
PMID:16128596 PMID:15194590
RGD:7207089 , RGD:7207131
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp8
matrix metallopeptidase 8
ISO
protein:increased expression:synovial fluid, serum (human)
RGD
PMID:15194590
RGD:7207131
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:synovial fluid, serum (human)
RGD
PMID:15194590
RGD:7207131
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Msn
moesin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Mtor
mechanistic target of rapamycin kinase
treatment
ISO
RGD
PMID:24651621 PMID:22084394
RGD:10003163 , RGD:10003165
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Mvp
major vault protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:181,594,734...181,622,336
Ensembl chr 1:181,594,734...181,622,380
G
Myh13
myosin heavy chain 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr10:52,012,779...52,068,960
Ensembl chr10:52,009,425...52,068,951
G
Myl3
myosin light chain 3
ISS
MouseDO
NCBI chr 8:110,738,669...110,744,814
Ensembl chr 8:110,738,661...110,744,816
G
Napepld
N-acyl phosphatidylethanolamine phospholipase D
IEP
protein:increased expression:spinal cord
RGD
PMID:20722027
RGD:10412653
NCBI chr 4:13,360,532...13,398,815
Ensembl chr 4:13,361,006...13,398,748
G
Ncor2
nuclear receptor co-repressor 2
susceptibility
ISO
RGD
PMID:15334463
RGD:1625347
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
G
Ndufs8
NADH:ubiquinone oxidoreductase core subunit S8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:201,140,585...201,144,573
Ensembl chr 1:201,140,585...201,144,511
G
Ndufv1
NADH:ubiquinone oxidoreductase core subunit V1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
G
Nfatc1
nuclear factor of activated T-cells 1
treatment
IEP
RGD
PMID:34738623
RGD:329328930
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Ngf
nerve growth factor
treatment
IMP
RGD
PMID:33806315 PMID:25677108
RGD:402463969 , RGD:402463970
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
G
Opa1
OPA1, mitochondrial dynamin like GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
G
P3h3
prolyl 3-hydroxylase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 4:157,646,242...157,662,035
Ensembl chr 4:157,646,243...157,662,035
G
Pdcd6ip
programmed cell death 6 interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773
G
Pdha1
pyruvate dehydrogenase E1 subunit alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr X:34,700,481...34,714,309
Ensembl chr X:34,700,409...34,714,311
G
Pecam1
platelet and endothelial cell adhesion molecule 1
IEP
mRNA:increased expression:tibia (rat)
RGD
PMID:21864409
RGD:6771362
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
mRNA:increased expression:cartilage tissue (human)
RGD
PMID:31472145
RGD:152177908
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Plcd1
phospholipase C, delta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 8:118,795,196...118,818,186
Ensembl chr 8:118,795,201...118,818,186
G
Plod2
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
G
Pls3
plastin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
G
Pomc
proopiomelanocortin
ISO
RGD
PMID:21378032
RGD:5508809
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Pou3f3
POU class 3 homeobox 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 9:44,945,872...44,948,998
Ensembl chr 9:44,945,872...44,948,992
G
Pparg
peroxisome proliferator-activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp2r1a
protein phosphatase 2 scaffold subunit A alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
G
Psmb1
proteasome 20S subunit beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:56,442,432...56,463,544
Ensembl chr 1:56,420,618...56,463,560
G
Ptgs2
prostaglandin-endoperoxide synthase 2
susceptibility
ISO
DNA:SNP (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32004530 PMID:15334463
RGD:1625347
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ran
RAN, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Rcn3
reticulocalbin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:95,564,503...95,573,762
Ensembl chr 1:95,564,380...95,573,725
G
Runx2
RUNX family transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
S100a4
S100 calcium-binding protein A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16948116
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
Scrn1
secernin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 4:83,632,125...83,694,225
Ensembl chr 4:83,632,131...83,693,852
G
Sdcbp
syndecan binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 5:19,473,499...19,517,188
Ensembl chr 5:19,489,961...19,527,572
G
Sdha
succinate dehydrogenase complex flavoprotein subunit A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 1:28,935,965...28,960,936
Ensembl chr 1:28,940,164...28,961,535
G
Sec23a
Sec23 homolog A, COPII coat complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 6:76,658,793...76,706,125
Ensembl chr 6:76,658,427...76,706,035
G
Serpina1
serpin family A member 1
IEP
RGD
PMID:20434574
RGD:2324964
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
G
Sgcg
sarcoglycan, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr15:35,388,836...35,435,072
Ensembl chr15:35,386,534...35,435,148
G
Slc2a1
solute carrier family 2 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18973239
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Smad3
SMAD family member 3
ISO ISS
CTD Direct Evidence: marker/mechanism
CTD MouseDO
PMID:21217753 PMID:22772368
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528 PMID:18784066 PMID:22108257
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Tent5a
terminal nucleotidyltransferase 5A
susceptibility
ISO
DNA:repeats: :
RGD
PMID:25231575
RGD:14390133
NCBI chr 8:86,222,294...86,229,045
Ensembl chr 8:86,225,357...86,229,045
G
Tfpi2
tissue factor pathway inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30664745
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr1
transforming growth factor, beta receptor 1
ISS
OMIM:140600 | OMIM:165720 | OMIM:607850 | OMIM:612400
MouseDO
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Tgm2
transglutaminase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Tlr8
toll-like receptor 8
ISO
ClinVar Annotator: match by term: Osteoarthritis
ClinVar
NCBI chr X:27,091,780...27,116,092
Ensembl chr X:27,091,778...27,116,549
G
Tnfrsf10b
TNF receptor superfamily member 10b
IEP
RGD
PMID:14872496
RGD:2290500
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf11b
TNF receptor superfamily member 11B
disease_progression
ISO
RGD
PMID:15334463
RGD:1625347
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfsf10
TNF superfamily member 10
IEP
RGD
PMID:14872496
RGD:2290500
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnfsf15
TNF superfamily member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30664745
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Trap1
TNF receptor-associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr10:11,464,882...11,498,931
Ensembl chr10:11,464,821...11,498,981
G
Trim2
tripartite motif-containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:169,500,634...169,652,927
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21964574
NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
G
Txnrd1
thioredoxin reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Vdac2
voltage-dependent anion channel 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16876394 PMID:18784066
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Ywhaq
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18784066
NCBI chr 6:40,935,714...40,966,240
Ensembl chr 6:40,935,949...40,966,273
G
Cfap96
cilia and flagella associated protein 96
ISO
ClinVar Annotator: match by term: Hip dysplasia, Beukes type | ClinVar Annotator: match by term: Osteoarthropathy, premature degenerative, of hip
ClinVar
PMID:25741868 PMID:25741905 PMID:28492532 PMID:33473208
NCBI chr16:46,291,075...46,315,616
Ensembl chr16:46,291,311...46,315,625
G
Ufsp2
UFM1-specific peptidase 2
ISO
ClinVar Annotator: match by term: Hip dysplasia, Beukes type | ClinVar Annotator: match by term: Osteoarthropathy, premature degenerative, of hip CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:2389793 PMID:21228277 PMID:25741868 PMID:25741905 PMID:26428751 PMID:28492532 PMID:28892125 PMID:33473208 More...
NCBI chr16:46,272,016...46,291,080
Ensembl chr16:46,272,016...46,291,059
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Familial digital arthropathy-brachydactyly
OMIM CTD ClinVar
PMID:4056805 PMID:8179305 PMID:11891693 PMID:20037586 PMID:20037587 PMID:20037588 PMID:20104247 PMID:20460441 PMID:21288981 PMID:21336783 PMID:21454511 PMID:21964574 PMID:22702953 PMID:24575025 PMID:24789864 PMID:24963089 PMID:25256292 PMID:25741868 PMID:25900305 PMID:26110311 PMID:26392352 PMID:26467025 PMID:26948711 PMID:27751652 PMID:28251916 PMID:28492532 PMID:29858556 PMID:30230566 PMID:30373780 More...
NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
G
Esr1
estrogen receptor 1
no_association
ISO
DNA:SNPs:exons: (rs2077647, rs1801132) (human)
RGD
PMID:19884274
RGD:10045830
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
no_association
ISO
DNA:SNPs:introns: (rs1256034, rs1256059, rs944460) (human)
RGD
PMID:19884274
RGD:10045830
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Il4
interleukin 4
no_association
ISO
DNA:SNPs:promoter, 5' utr, intron:multiple
RGD
PMID:20219689
RGD:10402786
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
no_association
ISO
DNA:SNPs:promoter, exons:multiple
RGD
PMID:20219689
RGD:10402786
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Anxa2
annexin A2
disease_progression
ISO
protein:increased expression:chondrocyte:
RGD
PMID:10903884
RGD:10053727
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Anxa5
annexin A5
disease_progression
ISO
protein:increased expression:chondrocyte:
RGD
PMID:10903884
RGD:10053727
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
G
Ar
androgen receptor
ISO
DNA:repeat:exon:c.172(CAG)8-34 (human)
RGD
PMID:16098017
RGD:10043199
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Aspn
asporin
severity
ISO
mRNA:increased expression:cartilage: DNA:repeats:exon:
RGD
PMID:15640800 PMID:15640800
RGD:9684965 , RGD:9684965
NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
G
B2m
beta-2 microglobulin
ISO
protein:increased expression:serum
RGD
PMID:18795399
RGD:6482710
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
Bax
BCL2 associated X, apoptosis regulator
treatment
IEP
RGD
PMID:20131282
RGD:6907382
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IEP
RGD
PMID:20131282
RGD:6907382
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bglap
bone gamma-carboxyglutamate protein
ISO IDA
RGD
PMID:22294259 PMID:21387139
RGD:6483563 , RGD:6483595
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Ccr2
C-C motif chemokine receptor 2
ISO
mRNA,protein:increased expression:dorsal root ganglion:
RGD
PMID:23185004
RGD:8661785
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
G
Cd36
CD36 molecule
disease_progression
ISO IEP
RGD
PMID:21765106 PMID:19342682
RGD:6893494 , RGD:6893565
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Ctnnb1
catenin beta 1
IEP
protein:increased expression:cartilage:
RGD
PMID:22702043
RGD:10395278
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISO
DNA:SNP:intron, 5' utr: (rs1062033) (human)
RGD
PMID:20417295
RGD:10045662
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Ddr2
discoidin domain receptor tyrosine kinase 2
ameliorates
IEP
RGD
PMID:31258642
RGD:150519887
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Dgat2
diacylglycerol O-acyltransferase 2
severity
ISO
mRNA,protein:increased expression:fat pad:
RGD
PMID:21765106
RGD:6893494
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
IMP
RGD
PMID:20131282
RGD:6907382
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
IEP
RGD
PMID:25435813
RGD:13506963
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
ISO
protein:increased expression:serum:
RGD
PMID:22275171
RGD:10401792
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
G
Epas1
endothelial PAS domain protein 1
no_association
ISO
DNA:SNP:5' utr: (rs17039192) (human)
RGD
PMID:22247019 PMID:20495570
RGD:10395367 , RGD:10395368
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:25422652
RGD:10400892
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Esr1
estrogen receptor 1
ISO
DNA:repeat:promoter:-1174(TA)9-25 (human) DNA:polymorphisms, haplotype:intron, exon DNA:SNP:cds:c.1782G>A (rs2228480) (human) DNA:SNPs:intron: (rs2234693, rs9340799) (human)
RGD
PMID:16098017 PMID:15380041 PMID:20128071 PMID:24772413
RGD:10043199 , RGD:10045840 , RGD:10045835 , RGD:10045829
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
ISO
DNA:repeat:intron:c.1092+3607(CA)13-27 (human)
RGD
PMID:16098017
RGD:10043199
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
ISO
RGD
PMID:21041276
RGD:5147774
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fgfr3
fibroblast growth factor receptor 3
treatment
ISO
RGD
PMID:27159076
RGD:11568056
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Gdf5
growth differentiation factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 3:144,454,316...144,458,508
Ensembl chr 3:144,454,338...144,458,612
G
Gsr
glutathione-disulfide reductase
ISO
protein:increased expression:synovial fluid
RGD
PMID:16289733
RGD:10401830
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hmgb1
high mobility group box 1
severity
ISO
protein:increased expression:synovial fluid mRNA:decreased expression:articular cartilage
RGD
PMID:21968272 PMID:19139395
RGD:10402061 , RGD:10402184
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgb2
high mobility group box 2
severity
ISO
mRNA:decreased expression:articular cartilage
RGD
PMID:19139395 PMID:19139395
RGD:10402184 , RGD:10402184
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
ISO
mRNA:increased expression:tibial plateaux (mouse) mRNA:decreased expression:blood (human)
RGD
PMID:9497939 PMID:16139532
RGD:10412655 , RGD:10429075
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Igf1
insulin-like growth factor 1
disease_progression severity
ISO IEP
protein:decreased expression:plasma (rat) mRNA:increased expression:meniscus:
RGD
PMID:8461919 PMID:17133593 PMID:9497937 PMID:20633672
RGD:10045862 , RGD:10003130 , RGD:10046057 , RGD:10045868
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
ISO
RGD
PMID:8948288
RGD:10045874
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Il1a
interleukin 1 alpha
IEP ISO
protein:increased expression:cartilage cell:
RGD
PMID:24534736 PMID:9497937 PMID:9034998
RGD:10045944 , RGD:10046057 , RGD:10045946
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il2
interleukin 2
severity
ISO
protein:increased expression:synovial fluid:
RGD
PMID:22035391
RGD:5687147
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
susceptibility
IDA ISO
DNA:repeat:intron: (rs8179190) (human)
RGD
PMID:18182309 PMID:24406619
RGD:2317291 , RGD:10402787
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Kl
Klotho
susceptibility
ISO
DNA:SNPs:promoter,exon:395G>A,2998C>T(human)
RGD
PMID:18465812
RGD:10403041
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Lep
leptin
ISO
protein:decreased expression:serum:
RGD
PMID:23575542
RGD:10411887
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lepr
leptin receptor
susceptibility
ISO
protein:increased expression:serum: DNA:SNP:cds:668A>G(human)
RGD
PMID:23575542 PMID:23575542
RGD:10411887 , RGD:10411887
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
G
Lpar1
lysophosphatidic acid receptor 1
susceptibility
ISO
DNA:snp:promoter:g.-2820G>A (rs10980705) (human)
RGD
PMID:18325907
RGD:10054291
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
G
Ltbp1
latent transforming growth factor beta binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
G
Mir219a1
microRNA 219a-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35962723
NCBI chr20:4,829,687...4,829,796
Ensembl chr20:4,829,687...4,829,796
G
Mir223
microRNA 223
IEP
RNA:increased expression:synovial membrane
RGD
PMID:30106113
RGD:25824950
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
G
Mmp1
matrix metallopeptidase 1
treatment
IEP
RGD
PMID:21167838
RGD:8549737
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp13
matrix metallopeptidase 13
ameliorates
IEP
RGD
PMID:31258642
RGD:150519887
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp3
matrix metallopeptidase 3
treatment
IMP
RGD
PMID:22114772
RGD:8694098
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Penk
proenkephalin
treatment
IEP
RGD
PMID:21928671
RGD:10003115
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Ptges
prostaglandin E synthase
IEP
RGD
PMID:17530714
RGD:2300093
NCBI chr 3:14,177,892...14,189,236
G
Sbno1
strawberry notch homolog 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr12:32,175,176...32,234,200
Ensembl chr12:32,185,485...32,230,158
G
Slc26a2
solute carrier family 26 member 2
susceptibility
ISO
DNA:deletion:promoter:-716_-713del4A(human)
RGD
PMID:11558903
RGD:13208866
NCBI chr18:54,648,276...54,666,627
Ensembl chr18:54,652,951...54,666,626
G
Tgfa
transforming growth factor alpha
IEP
protein:increased expression:cartilage
RGD
PMID:17968906
RGD:2317486
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Vdr
vitamin D receptor
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Wwp2
WW domain containing E3 ubiquitin protein ligase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr19:35,346,826...35,471,251
Ensembl chr19:35,346,814...35,472,699
G
Col2a1
collagen type II alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Namaqualand hip dysplasia | ClinVar Annotator: match by term: Osteoarthritis with mild chondrodysplasia
OMIM CTD ClinVar
PMID:1905723 PMID:1975693 PMID:1985108 PMID:7695699 PMID:7757086 PMID:7977371 PMID:8218237 PMID:8423604 PMID:8507190 PMID:8702139 PMID:8893763 PMID:9016532 PMID:9711874 PMID:10372559 PMID:15895462 PMID:16155195 PMID:17078022 PMID:17347327 PMID:18272325 PMID:18276201 PMID:19344236 PMID:25504618 PMID:25592122 PMID:25604898 PMID:25741868 PMID:25741869 PMID:26037341 PMID:26443184 PMID:26467025 PMID:26626311 PMID:28492532 PMID:34008892 More...
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Becn1
beclin 1
treatment
IEP
RGD
PMID:23589102
RGD:11561955
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bmp4
bone morphogenetic protein 4
ISO
RGD
PMID:19404941
RGD:9068434
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Casp3
caspase 3
treatment
IEP
RGD
PMID:29621761
RGD:13782275
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
treatment
IEP
RGD
PMID:29621761
RGD:13782275
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
treatment
IEP
RGD
PMID:29621761
RGD:13782275
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
treatment
IEP
RGD
PMID:29621761
RGD:13782275
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Col1a1
collagen type I alpha 1 chain
treatment
IEP
RGD
PMID:25128628
RGD:11041187
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Ddr2
discoidin domain receptor tyrosine kinase 2
treatment
IEP
RGD
PMID:25975052
RGD:150429975
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Fgfr1
Fibroblast growth factor receptor 1
ISO
RGD
PMID:22833219
RGD:10402072
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
G
Flt1
Fms related receptor tyrosine kinase 1
ISO
RGD
PMID:23041435
RGD:10402106
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
treatment
IMP
RGD
PMID:16394269
RGD:10402538
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Lrpap1
LDL receptor related protein associated protein 1
IEP
mRNA:decreased expression:knee
RGD
PMID:24754147
RGD:10412054
NCBI chr14:75,651,371...75,663,380
Ensembl chr14:75,651,376...75,665,414
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP
RGD
PMID:23589102
RGD:11561955
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
G
Mapk3
mitogen activated protein kinase 3
IEP
RGD
PMID:29364174
RGD:13800565
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Ncam1
neural cell adhesion molecule 1
IEP
protein:decreased expression:skeletal joint
RGD
PMID:31742919
RGD:40924673
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Serpinf1
serpin family F member 1
severity
ISO
RGD
PMID:28122611
RGD:27226703
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
G
Ulk1
unc-51 like autophagy activating kinase 1
treatment
IEP
RGD
PMID:23589102
RGD:11561955
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
G
Adamts5
ADAM metallopeptidase with thrombospondin type 1 motif, 5
IEP
mRNA:increased expression:cartilage
RGD
PMID:22670655
RGD:10043109
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
G
Aspn
asporin
ISO
mRNA:increased expression:cartilage:
RGD
PMID:15640800
RGD:9684965
NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041
G
Astn2
astrotactin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 5:78,758,142...79,744,021
Ensembl chr 5:78,758,142...79,748,273
G
Chadl
chondroadherin-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28319091 PMID:30374069
NCBI chr 7:113,205,323...113,218,678
Ensembl chr 7:113,210,748...113,217,272
G
Col10a1
collagen type X alpha 1 chain
IEP
mRNA, protein:increased expression:cartilage
RGD
PMID:22670655
RGD:10043109
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
G
Col11a1
collagen type XI alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
G
Col1a1
collagen type I alpha 1 chain
no_association susceptibility
ISO
DNA:SNP:intron:g.2046G>T (human)
RGD
PMID:17187661 PMID:9811048 PMID:15880349
RGD:5688305 , RGD:5688330 , RGD:5688306
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Comp
cartilage oligomeric matrix protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28319091
NCBI chr16:19,047,206...19,055,584
Ensembl chr16:19,047,207...19,055,845
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30664745
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
G
Diablo
diablo, IAP-binding mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30664745
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
G
Esr1
estrogen receptor 1
ISO
DNA:SNP:intron:g.-397T>C (human)
RGD
PMID:17419075
RGD:10045661
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Filip1
filamin A interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549
G
Gdf5
growth differentiation factor 5
ISO
ClinVar Annotator: match by term: Osteoarthritis, hip
ClinVar
PMID:17384641 PMID:28492532
NCBI chr 3:144,454,316...144,458,508
Ensembl chr 3:144,454,338...144,458,612
G
Ghr
growth hormone receptor
ISO
associated with Acromegaly;DNA:deletion:exon:
RGD
PMID:19864451
RGD:10003142
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Hdac9
histone deacetylase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
G
Hfe
homeostatic iron regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Il11
interleukin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069 PMID:30664745
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
G
Il4r
interleukin 4 receptor
susceptibility no_association
ISO
DNA:SNPs:multiple DNA:missense mutations:cds:p.S411L, p.S727A (rs1805013, rs1805016) (human)
RGD
PMID:14745651 PMID:19036616
RGD:10402782 , RGD:10402784
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Itih1
inter-alpha trypsin inhibitor, heavy chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr16:6,122,246...6,136,363
Ensembl chr16:6,122,248...6,136,363
G
Lmx1b
LIM homeobox transcription factor 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 3:16,862,195...16,940,899
Ensembl chr 3:16,862,195...16,940,899
G
Ltbp3
latent transforming growth factor beta binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 1:203,029,412...203,045,975
Ensembl chr 1:203,029,877...203,045,975
G
Mapt
microtubule-associated protein tau
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30664745
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Mmp13
matrix metallopeptidase 13
IEP
mRNA, protein:increased expression:cartilage
RGD
PMID:22670655
RGD:10043109
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Runx2
RUNX family transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
Smad3
SMAD family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Smo
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
G
Tnc
tenascin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30374069
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Acan
aggrecan
ISO
ClinVar Annotator: match by term: Short stature and advanced bone age | ClinVar Annotator: match by term: Short stature and advanced bone age, with early-onset osteoarthritis | ClinVar Annotator: match by term: Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans | ClinVar Annotator: match by term: Short stature-advanced bone age-early-onset osteoarthritis syndrome CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:14216462 PMID:16080123 PMID:19110214 PMID:20137779 PMID:24762113 PMID:25741789 PMID:25741868 PMID:27710243 PMID:27870580 PMID:28331218 PMID:28492532 PMID:29769040 PMID:31841439 PMID:34922359 PMID:36714562 More...
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
G
Dusp1
dual specificity phosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34697729
NCBI chr10:16,680,478...16,683,275
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34697729
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Lrp5
LDL receptor related protein 5
susceptibility
ISO
DNA:polymorphism:cds:p.Q89R(human)
RGD
PMID:17202888
RGD:12792278
NCBI chr 1:200,814,247...200,917,581
Ensembl chr 1:200,814,250...200,917,581
G
Mir337
microRNA 337
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34697729
NCBI chr 6:128,538,903...128,538,999
Ensembl chr 6:128,538,902...128,538,998
G
Skp2
S-phase kinase associated protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34697729
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34697729
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Atf6
activating transcription factor 6
IEP
mRNA,protein:increased expression:chondrocyte
RGD
PMID:31007149
RGD:34888237
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Becn1
beclin 1
IEP
RGD
PMID:31007149
RGD:34888237
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Casp12
caspase 12
IEP
mRNA,protein:increased expression:chondrocyte
RGD
PMID:31007149
RGD:34888237
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Ddit3
DNA-damage inducible transcript 3
IEP
mRNA,protein:increased expression:chondrocyte
RGD
PMID:31007149
RGD:34888237
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dll4
delta like canonical Notch ligand 4
disease_progression
IEP
RGD
PMID:28147322
RGD:155791443
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
IEP
mRNA,protein:increased expression:chondrocyte
RGD
PMID:31007149
RGD:34888237
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Ern1
endoplasmic reticulum to nucleus signaling 1
IEP
RGD
PMID:31007149
RGD:34888237
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Fas
Fas cell surface death receptor
IEP
mRNA:increased expression:mandibular condyle, cartilage (rat)
RGD
PMID:23934157
RGD:8663479
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Hspa5
heat shock protein family A (Hsp70) member 5
IEP
mRNA,protein:increased expression:chondrocyte
RGD
PMID:31007149
RGD:34888237
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
IEP
RGD
PMID:31007149
RGD:34888237
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Rps6
ribosomal protein S6
IEP
RGD
PMID:31007149
RGD:34888237
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all